
58.58 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 48.61 Today|||52-Week Range 69.60 | +10.11% Year-to-Date |
USNA vs. ZTS: Which Stock Is the Better Value Option? Sep 13 / Zacks.com - Paid Partner Content |
Previous close | 59.76 |
Today’s open | 59.50 |
Day’s range | 58.29 - 59.81 |
Volume | 58,374 |
Average volume (3 months) | 65,881 |
Market cap | $1.2B |
Earnings growth (last year) | -37.72% |
Earnings growth (this year) | -15.76% |
Earnings growth (next 5 years) | +12.00% |
Revenue growth (last year) | -15.83% |
P/E ratio | 17.8 |
Price/Sales | 1.03 |
Price/Book | 2.66 |
---- | ||
CRONCronos Group Inc | -0.07 | -3.21% |
--Abivax SA | 0.00 | 0.00% |
---- |
Next reporting date | October 24, 2023 |
EPS forecast (this quarter) | $0.68 |
Annual revenue (last year) | $998.6M |
Annual profit (last year) | $69.4M |
Net profit margin | 6.94% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Salt Lake City, Utah |